HONG KONG -- Chinese medical technology startup SiBionics has raised nearly 500 million yuan ($72 million) in a Series D round of financing to expand its development of artificial intelligence-based devices for chronic disease management.
Company will use funds to expand at home and overseas

Founded in 2015, SiBionics is developing a pipeline of products focused on a range of diseases. (Source image from SiBionics website)
HONG KONG -- Chinese medical technology startup SiBionics has raised nearly 500 million yuan ($72 million) in a Series D round of financing to expand its development of artificial intelligence-based devices for chronic disease management.